Listen "Update on Intravitreal Injectable Drugs and Dry AMD Treatments"
Episode Synopsis
Drs. M. Ali Khan, Ajay Kuriyan, and Sarah Read join host Jay Sridhar to discuss recent developments in intravitreal injectable drugs, including 8-mg aflibercept not initially approved by the FDA, the upcoming PDUFA date for on-label bevacizumab, and approaching injections for dry age-related macular degeneration (AMD). For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
More episodes of the podcast Experts InSight
CMS Cuts Rock Ophthalmology and Medicine
21/08/2025
A Journey Through Vision Loss
08/08/2025
Updates on Optic Disc Drusen
25/07/2025
Intraocular Pressure Variance
27/06/2025
Updates in Amblyopia Treatment
12/06/2025